Nextage Therapeutics Ltd (TLV:NXTG)
Israel · Delayed Price · Currency is ILS · Price in ILA 59.00
+8.10 (15.91%)
At close: Jun 12, 2026
Nextage Therapeutics Cash Flow Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 2.84 | -3.28 | -3.88 | -5.59 | -7.73 | -15.97 |
Depreciation & Amortization | -0.04 | 0.1 | 0.13 | 0.06 | 0.19 | 0.1 |
Asset Writedown & Restructuring Costs | - | - | - | - | 1.23 | - |
Loss (Gain) on Equity Investments | -0.44 | - | - | -0.02 | 0.07 | - |
Stock-Based Compensation | 0 | 0 | 0.09 | 0.47 | 2.02 | - |
Other Operating Activities | 0.56 | -0.18 | -0.32 | -0.38 | -0.69 | 12.9 |
Change in Accounts Receivable | -0.55 | 0.21 | -0.24 | 0.02 | -0.03 | 0.01 |
Change in Accounts Payable | -0.47 | 0.12 | -0.01 | -0.31 | 0.24 | -0.98 |
Change in Other Net Operating Assets | 0.99 | 2.24 | 1.97 | -0.25 | 0.73 | -2.38 |
Operating Cash Flow | -2.32 | -0.8 | -2.26 | -6.01 | -3.97 | -6.31 |
Capital Expenditures | - | - | - | -0 | - | -0.01 |
Cash Acquisitions | 0.3 | - | - | - | - | 7.98 |
Investment in Securities | -0.03 | - | - | - | - | -0.02 |
Other Investing Activities | -0.18 | -0.18 | 0 | 0.02 | -0.06 | - |
Investing Cash Flow | 0.09 | -0.18 | 0 | 0.02 | -0.06 | 7.95 |
Short-Term Debt Issued | - | - | 0.12 | - | - | - |
Long-Term Debt Issued | - | 0.03 | 0.5 | 0.21 | 0.95 | - |
Total Debt Issued | -0.31 | 0.03 | 0.62 | 0.21 | 0.95 | - |
Short-Term Debt Repaid | - | -0.1 | -0.21 | -0.2 | -0.19 | -0.06 |
Long-Term Debt Repaid | - | -0.03 | -0.09 | -0.03 | -0.07 | -1.8 |
Total Debt Repaid | -1.23 | -0.13 | -0.3 | -0.23 | -0.26 | -1.86 |
Net Debt Issued (Repaid) | -1.54 | -0.1 | 0.32 | -0.02 | 0.69 | -1.86 |
Issuance of Common Stock | 3.33 | 0.64 | 1.16 | 3.44 | 0.18 | 2.26 |
Other Financing Activities | 0.11 | - | - | -0.03 | 4.6 | - |
Financing Cash Flow | 1.9 | 0.54 | 1.48 | 3.39 | 5.47 | 0.4 |
Foreign Exchange Rate Adjustments | 0.03 | 0.03 | 0.13 | 0.39 | -0.2 | - |
Net Cash Flow | -0.3 | -0.4 | -0.65 | -2.21 | 1.23 | 2.03 |
Free Cash Flow | -2.32 | -0.8 | -2.26 | -6.02 | -3.97 | -6.32 |
Free Cash Flow Margin | -954.73% | -192.49% | -258.22% | - | -4367.03% | -3309.42% |
Free Cash Flow Per Share | -0.13 | -0.02 | -0.08 | -0.22 | -0.15 | -0.55 |
Cash Interest Paid | - | - | 0.03 | 0.03 | 0.04 | 0.09 |
Levered Free Cash Flow | 5.99 | 0.5 | -0.56 | - | - | - |
Unlevered Free Cash Flow | 6.01 | 0.52 | -0.53 | - | - | - |
Change in Working Capital | -0.02 | 2.57 | 1.72 | -0.54 | 0.94 | -3.34 |